Pfizer earnings in the third quarter of 2026.
- Rev: $16.58B (is $15.87B).
- Adj EPS: 87c (estimated 73c).
- See Rev FY: $62.0B to $64.0B (previously $60.5B to $62.5B).
- Sees FY Adj EPS: $2.95 to $3.05 (est. $2.96; previously $2.80 to $3).
Pfizer earnings in the third quarter of 2026.
More on Radar
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in